20 (AIDX) EPS (Basic) (2025 - 2026)
20 (AIDX) reported EPS (Basic) of -$0.28 for Q1 2026, down 75.0% on a YoY basis from -$1.12 in Q1 2025, and down 75.0% quarter-over-quarter from -$0.16 in Q1 2025.
20 (AIDX) EPS (Basic) (2025 - 2026) Analysis & Trends
20 has reported EPS (Basic) for 2 years, with the latest figure at -$0.28 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 75.0% year-over-year to -$0.28; the trailing twelve-month figure through Mar 2026 stood at -$0.44 (changed N/A YoY), and the FY2025 full-year result was -$0.76, up 34.48% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.28, down from -$0.16 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.16 in Q1 2025, with the low at -$0.28 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.52 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.25 |
| 10 | 20 | - | - | 62,884.00 | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Mar 31, 2025 | -0.16 |